124 related articles for article (PubMed ID: 2762260)
1. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
Koev D; Todorova S; Diankov L; Khristova D; Tsachev K
Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094
[TBL] [Abstract][Full Text] [Related]
3. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
Peacock M; Heyburn PJ; Aaron JE
Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
[No Abstract] [Full Text] [Related]
4. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
Shiraki M; Orimo H; Ito H; Akiguchi I; Nakao J; Takahashi R; Ishizuka S
Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
[TBL] [Abstract][Full Text] [Related]
5. The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia.
Peacock M; Aaron JE; Heyburn PJ; Nordin BE
Adv Exp Med Biol; 1977; 81():431-40. PubMed ID: 899935
[No Abstract] [Full Text] [Related]
6. Vitamin D metabolites and bone mineralization in man.
Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
[TBL] [Abstract][Full Text] [Related]
7. Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia.
Long RG; Varghese Z; Meinhard EA; Skinner RK; Wills MR; Sherlock S
Br Med J; 1978 Jan; 1(6105):75-7. PubMed ID: 620204
[TBL] [Abstract][Full Text] [Related]
8. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
[TBL] [Abstract][Full Text] [Related]
9. [Experience in treating metabolic osteopathies with 1 alpha-hydroxyvitamin D3 (oksidevit)].
Babarykin DA; Reĭsner NA; Riabukha AN; Rozental' RL
Ter Arkh; 1991; 63(11):113-6. PubMed ID: 1810042
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone.
Fujita T; Nomura M; Okajima S; Furuya H
J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136
[TBL] [Abstract][Full Text] [Related]
11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
12. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
[TBL] [Abstract][Full Text] [Related]
13. Effect of phenytoin on bone and vitamin D metabolism.
Bell RD; Pak CY; Zerwekh J; Barilla DE; Vasko M
Ann Neurol; 1979 Apr; 5(4):374-8. PubMed ID: 220903
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of severe postmenopausal osteoporosis].
Reĭsner NA; Babarykin DA; Vorona IG; Riabukha AN; Rozental' RL
Probl Endokrinol (Mosk); 1988; 34(4):13-6. PubMed ID: 3194355
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
[No Abstract] [Full Text] [Related]
16. Short-term effects of 1-alpha-hydroxy-vitamin D3 in patients on corticosteroid treatment and in patients with senile osteoporosis.
Lindgren U; Lindholm S; Sarby B
Acta Med Scand; 1978; 204(1-2):89-92. PubMed ID: 685736
[TBL] [Abstract][Full Text] [Related]
17. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S; Lindholm TC
Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
Peacock M; Heyburn PJ; Aaron JE
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S
Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of anticonvulsant osteomalacia in adults (author's transl)].
Krause KH; Prager P; Schmidt-Gayk H; Ritz E
Dtsch Med Wochenschr; 1977 Dec; 102(51):1872-7. PubMed ID: 598289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
